Selective Irreversible Inhibitors of the Wnt-Deacylating Enzyme NOTUM Developed by Activity-Based Protein Profiling
Radu M Suciu1, Armand B Cognetta1, Zachary E Potter1
1The Skaggs Institute for Chemical Biology, Department of Chemical Physiology, The Scripps Research Institute, La Jolla, California 92037, United States.
Abstract:
Wnt proteins are secreted morphogens that play critical roles in embryonic development and tissue remodeling in adult organisms. Aberrant Wnt signaling contributes to diseases such as cancer. Wnts are modified by an unusual O-fatty acylation event (O-linked palmitoleoylation of a conserved serine) that is required for binding to Frizzled receptors. O-Palmitoleoylation of Wnts is introduced by the porcupine (PORCN) acyltransferase and removed by the serine hydrolase NOTUM. PORCN inhibitors are under development for oncology, while NOTUM inhibitors have potential for treating degenerative diseases. Here, we describe the use of activity-based protein profiling (ABPP) to discover and advance a class of N-hydroxyhydantoin (NHH) carbamates that potently and selectively inhibit NOTUM. An optimized NHH carbamate inhibitor, ABC99, preserves Wnt-mediated cell signaling in the presence of NOTUM and was also converted into an ABPP probe for visualizing NOTUM in native biological systems.
Insights
Researchers developed novel inhibitors targeting NOTUM, an enzyme that removes fatty acids from Wnt proteins. This discovery aids in understanding Wnt signaling and developing treatments for diseases like cancer and degenerative conditions.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Wnt proteins are crucial morphogens in development and tissue repair.
- Dysregulated Wnt signaling is linked to diseases, including cancer.
- Wnt lipidation by porcupine (PORCN) and de-lipidation by NOTUM are key regulatory steps.
Purpose of the Study:
- To discover and develop potent and selective inhibitors of the NOTUM enzyme.
- To explore the therapeutic potential of NOTUM inhibition in Wnt-related diseases.
Main Methods:
- Activity-based protein profiling (ABPP) was employed to identify NOTUM inhibitors.
- A class of N-hydroxyhydantoin (NHH) carbamates was discovered.
- An optimized inhibitor, ABC99, was developed and characterized.
Main Results:
- NHH carbamates potently and selectively inhibit NOTUM.
- The inhibitor ABC99 maintains Wnt signaling activity despite NOTUM presence.
- ABC99 was adapted as an ABPP probe for NOTUM visualization.
Conclusions:
- Novel NHH carbamate inhibitors of NOTUM were successfully developed using ABPP.
- These inhibitors offer potential therapeutic strategies for Wnt-related pathologies.
- The developed probe enables visualization of NOTUM in biological contexts.
Related Concept Videos
Enzymes
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Enzymes and Activation Energy
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Reversible and Irreversible Processes


